The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
STARS (NCT 07265661): Surgical timing after preoperative hypofractionated radiotherapy for patients with primary localized soft tissue sarcoma of the extremity and trunk—A randomized phase 2 clinical trial.
 
Marco Baia
No Relationships to Disclose
 
Alessandro Gronchi
Honoraria - Deciphera; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar; SpringWorks Therapeutics
Research Funding - Nanobiotix (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar
 
Claudia Sangalli
No Relationships to Disclose
 
Pierina Navarria
No Relationships to Disclose
 
Elena Clerici
No Relationships to Disclose
 
Matteo Mascherini
No Relationships to Disclose
 
Silvia Cammelli
No Relationships to Disclose
 
Daniela Greto
No Relationships to Disclose
 
Carlo Greco
No Relationships to Disclose
 
Federico Navarria
No Relationships to Disclose
 
Raimondo Piana
No Relationships to Disclose
 
Elisabetta Pennacchioli
No Relationships to Disclose
 
Maria Samaritana Buzzaccarini
No Relationships to Disclose
 
Rosalba Miceli
No Relationships to Disclose
 
Antonio Cannarozzo
No Relationships to Disclose
 
Alessia Rossetti
No Relationships to Disclose
 
Daniela Salvatore
No Relationships to Disclose
 
Gianluca Ignazzi
No Relationships to Disclose
 
Viviana Appolloni
No Relationships to Disclose
 
Silvia Stacchiotti
Honoraria - Gentili; GlaxoSmithKline; Peerview; PharmaMar; Servier
Consulting or Advisory Role - Bayer; deciphera; GlaxoSmithKline; Ikena Oncology; Ipsen; Merck Serono; Orion; Parabilis; Pharmaessentia; SERVIER; Sun Pharma
Research Funding - Abbisko Therapeutics (Inst); Advenchen Laboratories (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Merck Serono; Novartis (Inst); PharmaMar (Inst); SERVIER; SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar